A Comprehensive Review of Andrographis paniculata (Burm. f.) Nees and Its Constituents as Potential Lead Compounds for COVID-19 Drug Discovery.
- 2022-07-13
- Review
- Molecules (Basel, Switzerland) 27(14)
- Aekkhaluck Intharuksa
- Warunya Arunotayanun
- Wipawadee Yooin
- Panee Sirisa-Ard
- PubMed: 35889352
- DOI: 10.3390/molecules27144479
- Low evidence
existing publications regarding randomized controlled trials demonstrated that the use of A. paniculata alone or in combination was superior to the placebo in reducing the severity of upper respiratory tract infection (URTI) manifestations, especially as part of early treatment, without serious side effects.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes